Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors.

ABSTRACT: We report the design and target validation of chimeric peptide EP45, a novel 45 amino acid monomeric dual agonist peptide that contains amino acid sequence motifs present within the blood glucose-lowering agent exendin-4 (Ex-4) and the appetite-suppressing agent PYY(3-36). In a new high-throughput FRET assay that provides real-time kinetic information concerning levels of cAMP in living cells, EP45 recapitulates the action of Ex-4 to stimulate cAMP production via the glucagon-like peptide-1 receptor (GLP-1R), while also recapitulating the action of PYY(3-36) to inhibit cAMP production via the neuropeptide Y₂ receptor (NPY2R). EP45 fails to activate glucagon or GIP receptors, whereas for cells that co-express NPY2R and adenosine A_2B receptors, EP45 acts in an NPY2R-med

SUBMITTER: Chepurny OG 

PROVIDER: S-EPMC5830615 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature